{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:31:58Z","timestamp":1780731118262,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cempra Inc"},{"DOI":"10.13039\/501100001069","name":"Women and Infants Research Foundation","doi-asserted-by":"publisher","award":["SF645"],"award-info":[{"award-number":["SF645"]}],"id":[{"id":"10.13039\/501100001069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012155","name":"Channel 7 Telethon Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012155","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.placenta.2014.09.009","type":"journal-article","created":{"date-parts":[[2014,9,21]],"date-time":"2014-09-21T21:32:15Z","timestamp":1411335135000},"page":"1043-1048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Trans-placental passage and anti-inflammatory effects of solithromycin in the human placenta"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5403-6266","authenticated-orcid":false,"given":"J.A.","family":"Keelan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pugazhenthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2014.09.009_bib1","first-page":"CD001058","article-title":"Antibiotics for preterm rupture of membranes","volume":"8","author":"Kenyon","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.placenta.2014.09.009_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.12.023","article-title":"Safety of macrolides during pregnancy","volume":"208","author":"Lin","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"20","key":"10.1016\/j.placenta.2014.09.009_bib3","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.placenta.2014.09.009_bib4","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1128\/AAC.01691-12","article-title":"The fetal safety of macrolides","volume":"57","author":"Dinur","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.placenta.2014.09.009_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2165\/11630920-000000000-00000","article-title":"The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study","volume":"35","author":"Bar-Oz","year":"2012","journal-title":"Drug Saf"},{"issue":"7","key":"10.1016\/j.placenta.2014.09.009_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/bdd.767","article-title":"Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages","volume":"32","author":"Togami","year":"2011","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib7","first-page":"23","article-title":"Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes","volume":"9","author":"Fietta","year":"1997","journal-title":"J\u00a0Chemother"},{"issue":"6","key":"10.1016\/j.placenta.2014.09.009_bib8","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/AAC.49.6.2372-2377.2005","article-title":"Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin","volume":"49","author":"Bosnar","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.placenta.2014.09.009_bib9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mob.2003.141","article-title":"Maternal and transplacental pharmacokinetics of azithromycin","volume":"188","author":"Ramsey","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0002-9378(16)37926-1","article-title":"The placental transfer of erythomycin","volume":"69","author":"Kiefer","year":"1955","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.placenta.2014.09.009_bib11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1471-0528.2000.tb13339.x","article-title":"The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin","volume":"107","author":"Heikkinen","year":"2000","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2010.05.016","article-title":"Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays","volume":"41","author":"Munic","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.placenta.2014.09.009_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1128\/AAC.48.3.809-814.2004","article-title":"Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin","volume":"48","author":"Sugie","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.placenta.2014.09.009_bib14","first-page":"389","article-title":"Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells","volume":"67","author":"Togami","year":"2012","journal-title":"Die Pharm"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1517\/17425255.2.1.51","article-title":"Active transport across the human placenta: impact on drug efficacy and toxicity","volume":"2","author":"Evseenko","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"10.1016\/j.placenta.2014.09.009_bib16","doi-asserted-by":"crossref","first-page":"e1000191","DOI":"10.1371\/journal.pmed.1000191","article-title":"The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis","volume":"6","author":"van den Broek","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.placenta.2014.09.009_bib17","first-page":"2012","article-title":"Antimicrobials for preterm birth prevention: an overview","author":"Subramaniam","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ogc.2011.12.007","article-title":"Antibiotics in the management of PROM and preterm labor","volume":"39","author":"Mercer","year":"2012","journal-title":"Obst Gynecol Clin North Am"},{"issue":"11","key":"10.1016\/j.placenta.2014.09.009_bib19","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1469-0691.2010.03155.x","article-title":"In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years","volume":"16","author":"Krausse","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.placenta.2014.09.009_bib20","first-page":"CD000246","article-title":"Prophylactic antibiotics for inhibiting preterm labour with intact membranes","volume":"12","author":"Flenady","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.placenta.2014.09.009_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.coph.2012.06.003","article-title":"Improving known classes of antibiotics: an optimistic approach for the future","volume":"12","author":"Bush","year":"2012","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"10.1016\/j.placenta.2014.09.009_bib22","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1128\/AAC.02411-14","article-title":"In\u00a0vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.placenta.2014.09.009_bib23","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1128\/AAC.00036-12","volume":"56","author":"Golparian","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.placenta.2014.09.009_bib24","first-page":"476","article-title":"The in\u00a0vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)","volume":"61","author":"Farrell","year":"2010","journal-title":"J\u00a0Infect"},{"issue":"5","key":"10.1016\/j.placenta.2014.09.009_bib25","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.00090-09","article-title":"Comparative in\u00a0vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101","volume":"53","author":"Waites","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.placenta.2014.09.009_bib26","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1128\/AAC.00197-13","article-title":"Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia","volume":"57","author":"Oldach","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.placenta.2014.09.009_bib27","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/AAC.01429-10","article-title":"Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects","volume":"55","author":"Still","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.112.200733","article-title":"A\u00a0novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-kappaB inhibition","volume":"345","author":"Kobayashi","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/AAC.01743-13","article-title":"Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model","volume":"58","author":"Keelan","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.placenta.2014.09.009_bib30","series-title":"ICAAC Conference","article-title":"Comparison of CEM-101 metabolism in mice, rats, monkeys and humans","author":"Pereira","year":"2010"},{"key":"10.1016\/j.placenta.2014.09.009_bib31","series-title":"CEM-101: an oral gavage study for effects on embryo-fetal development in rats with a toxicokinetic evaluation","first-page":"1","author":"Thorsrud","year":"2011"},{"issue":"9","key":"10.1016\/j.placenta.2014.09.009_bib32","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1128\/AAC.03187-14","article-title":"Maternal intravenous treatment with either azithromycin or solithromycin clears Ureaplasma parvum from the amniotic fluid in an ovine model of intrauterine infection","volume":"58","author":"Miura","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl.\u00a0A","key":"10.1016\/j.placenta.2014.09.009_bib33","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.placenta.2006.11.002","article-title":"Animal models of human placentation\u2013a review","volume":"28","author":"Carter","year":"2007","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.placenta.2014.09.009_bib34","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.tiv.2007.05.011","article-title":"The human placenta\u2013an alternative for studying foetal exposure","volume":"21","author":"Myren","year":"2007","journal-title":"Toxicol In\u00a0Vitro"},{"issue":"4","key":"10.1016\/j.placenta.2014.09.009_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.01.025","article-title":"Transfer of bisphenol A across the human placenta","volume":"202","author":"Balakrishnan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in\u00a0vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.reprotox.2010.01.006","article-title":"Quality assessment of a placental perfusion protocol","volume":"30","author":"Mathiesen","year":"2010","journal-title":"Reprod Toxicol"},{"issue":"4","key":"10.1016\/j.placenta.2014.09.009_bib38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0143-4004(85)80043-6","article-title":"Maternal to fetal movement of creatinine as a measure of perfusion efficiency and diffusional transfer in the isolated human placental lobule","volume":"6","author":"Eaton","year":"1985","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.placenta.2014.09.009_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0009-8981(71)90452-9","article-title":"Creatinine assay in the presence of protein","volume":"32","author":"Cook","year":"1971","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.placenta.2014.09.009_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/molehr\/gas001","article-title":"Oxysterols exert proinflammatory effects in placental trophoblasts via TLR4-dependent, cholesterol-sensitive activation of NF-kappaB","volume":"18","author":"Aye","year":"2012","journal-title":"Mol Hum Reprod"},{"issue":"5","key":"10.1016\/j.placenta.2014.09.009_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.02.031","article-title":"Innate inflammatory responses of human decidual cells to periodontopathic bacteria","volume":"202","author":"Keelan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2014.09.009_bib42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0003-2697(86)90091-6","article-title":"Adaption of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions","volume":"153","author":"Redinbaugh","year":"1986","journal-title":"Anal Biochem"},{"issue":"1\u20132","key":"10.1016\/j.placenta.2014.09.009_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mce.2012.05.009","article-title":"Ceramide biosynthesis and metabolism in trophoblast syncytialization","volume":"362","author":"Singh","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.placenta.2014.09.009_bib44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1067\/mob.2003.171","article-title":"Placental passage of clarithromycin surpasses other macrolide antibiotics","volume":"188","author":"Witt","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.placenta.2014.09.009_bib45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1183\/09031936.00136712","article-title":"Long-term macrolide treatment for chronic respiratory disease","volume":"42","author":"Spagnolo","year":"2012","journal-title":"Eur Resp J"},{"issue":"Abstract 42","key":"10.1016\/j.placenta.2014.09.009_bib46","first-page":"A6586","article-title":"Solithromycin reduces inflammation in mice caused by bleomycin-induced lung injury","volume":"189","author":"Fernandes","year":"2014","journal-title":"Am J Crit Care Med"},{"issue":"5","key":"10.1016\/j.placenta.2014.09.009_bib47","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/bph.12187","article-title":"A\u00a0novel macrolide\/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition","volume":"169","author":"Kobayashi","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.placenta.2014.09.009_bib48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.taap.2009.09.005","article-title":"Toxic effects of low doses of bisphenol-A on human placental cells","volume":"241","author":"Benachour","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.placenta.2014.09.009_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mrgentox.2006.02.014","article-title":"Experimental methods to study human transplacental exposure to genotoxic agents","volume":"608","author":"Vahakangas","year":"2006","journal-title":"Mutat Res"},{"issue":"3","key":"10.1016\/j.placenta.2014.09.009_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0897.2010.00837.x","article-title":"Placental apoptosis in health and disease","volume":"64","author":"Sharp","year":"2010","journal-title":"Am J Reprod Immunol"},{"issue":"8","key":"10.1016\/j.placenta.2014.09.009_bib51","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.4049\/jimmunol.0802660","article-title":"Prevention of inflammatory activation of human gestational membranes in an ex\u00a0vivo model using a pharmacological NF-kappaB inhibitor","volume":"183","author":"Keelan","year":"2009","journal-title":"J\u00a0Immunol"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400414007851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400414007851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:50:18Z","timestamp":1758909018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400414007851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0143400414007851"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2014.09.009","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trans-placental passage and anti-inflammatory effects of solithromycin in the human placenta","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2014.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}